Trial intelligence / Profile preview

Diagnostic Performance of 18F-NaF-PET/CT in Bone Metastases

NCT05614518Phase 3Completed

Start
Mar 2021
Primary completion
Jun 2022
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of sodium fluoride f-18 in bone metastasis. Started Mar 2021; status: completed.

02

Drugs

sodium fluoride f-18
03

Conditions

bone metastasis

Beyond the preview

Go deeper on NCT05614518.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05614518.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call